title: Human liver allograft rejection: severity, prognosis, and response to treatment.
authors.affiliation: Australian National Liver Transplant Unit, Royal Prince Alfred Hospital, Sydney, Australia.
authors.forename: J A
authors.initials: JA
authors.lastname: McDonald
authors.forename: D M
authors.initials: DM
authors.lastname: Painter
authors.forename: R
authors.initials: R
authors.lastname: Bell
authors.forename: N D
authors.initials: ND
authors.lastname: Gallagher
authors.forename: A G
authors.initials: AG
authors.lastname: Sheil
authors.forename: G W
authors.initials: GW
authors.lastname: McCaughan
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D015704:CD4 Antigens / Q000276:immunology; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016031:Liver Transplantation / Q000276:immunology*; D011379:Prognosis; D016019:Survival Analysis
chemical_list: D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D015704:CD4 Antigens